Cencora Inc.

Healthcare · Medical Distribution

309.90$ -0.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Cencora Inc. (COR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 84,755 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement COR
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	37,561	38,169	37,147	38,707	39,120	40,466	41,034	43,142	43,297	45,392	43,320	45,239	45,638	47,865	47,418	45,367	49,245	52,517	49,154	53,406	58,912	59,629	57,719	60,065	61,174	62,847	63,457	66,947	68,922	72,253	68,414	74,241	79,050	81,487	75,454	80,664	83,729	85,932	78,356	84,755	332,771
Cost of Revenue	36,531	37,229	35,989	37,727	38,052	39,459	39,898	42,087	42,385	44,305	42,071	44,119	44,565	46,747	46,123	44,236	47,996	51,164	47,722	51,497	57,042	57,744	55,660	58,221	59,359	60,923	61,403	65,075	67,016	70,103	66,157	72,155	76,887	79,223	72,838	78,005	81,125	83,120	75,033	81,148	320,426
Gross Profit	1,030	940	1,159	980	1,068	1,008	1,136	1,056	912	1,088	1,249	1,120	1,073	1,118	1,294	1,130	1,249	1,353	1,433	1,909	1,870	1,884	2,060	1,843	1,815	1,924	2,054	1,872	1,907	2,150	2,258	2,087	2,163	2,264	2,616	2,658	2,603	2,812	3,323	3,607	12,345
Selling, General & Administrative	15	14	14	15	16	16	16	17	17	18	18	20	19	20	20	21	667	20	21	21	735	–	–	1,212	1,263	1,291	1,321	1,304	1,394	1,399	1,389	1,383	1,490	1,472	1,600	1,673	1,749	1,795	1,978	2,132	7,654
Total Operating Expenses	530	521	522	525	561	559	617	627	658	657	628	657	722	686	693	667	721	735	730	913	1,216	1,170	1,203	1,212	1,263	1,291	1,321	1,304	1,394	1,399	1,389	1,383	1,490	1,472	1,600	1,673	1,749	1,795	1,978	2,487	8,009
Operating Income	500	420	637	455	507	449	519	429	254	431	621	463	351	432	601	463	528	618	703	995	655	714	857	631	552	633	733	568	513	751	869	703	673	792	1,016	986	855	1,016	1,345	1,120	4,336
Interest Expense	37	38	38	37	36	37	50	53	49	49	50	49	48	42	42	39	36	35	35	53	60	57	55	58	62	61	72	68	74	59	77	59	54	61	132	117	109	93	154	141	498
Pre-Tax Income	192	363	593	133	-122	359	361	345	112	433	19	371	145	230	276	344	-6,143	528	567	574	554	596	728	476	382	593	512	609	446	783	467	628	125	620	929	896	-187	709	2,089	996	3,607
Income Tax Expense	46	116	181	83	173	-503	79	67	-82	41	-9.3	69	12	43	-695	57	-1,299	149	133	278	117	147	173	113	84	117	84	130	97	180	46	141	118	127	211	207	146	143	459	220	967
Net Income	144	247	411	50	-295	862	287	276	233	394	27	302	133	188	960	289	-4,846	375	435	292	438	449	548	407	295	480	435	480	351	602	421	483	3.4	489	718	687	-340	560	1,641	764	2,625
EBITDA	334	505	735	270	24	506	531	537	293	615	203	530	303	378	414	480	-6,006	665	705	754	791	830	960	707	615	827	827	953	797	1,119	822	966	458	961	1,323	1,269	183	1,041	2,502	1,407	5,134

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings